Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | PGD | P52209 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3789970 | 0.84 | TSHR (0.46) | TSHRALDH1A1PGD | |
| SCHEMBL19379354 | 0.78 | CYP2C9 (0.37) | TSHRLMNACYP2C19ALDH1A1PGD | |
| SCHEMBL9163310 | 0.73 | TSHR (0.46) | TSHRLMNACYP2C19ALDH1A1 | |
| SCHEMBL11430387 | 0.68 | LMNA (0.61) | TSHRLMNACYP2C19ALDH1A1 | |
| SCHEMBL19379139 | 0.68 | ALDH1A1 (0.36) | TSHRLMNACYP2C19ALDH1A1 | |
| SCHEMBL8816475 | 0.68 | LMNA (0.40) | TSHRLMNACYP2C19ALDH1A1 | |
| SCHEMBL8416129 | 0.67 | TSHR (0.50) | TSHRALDH1A1PGD | |
| SCHEMBL19398539 | 0.67 | TSHR (0.34) | TSHRLMNACYP2C19 | |
| SCHEMBL19395809 | 0.65 | TSHR (0.33) | TSHRLMNACYP2C19 | |
| SCHEMBL19379352 | 0.65 | TSHR (0.42) | TSHRALDH1A1PGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10093688-B2 | Non-aqueous liquid electrolyte, electricity storage device using same, and phosphorus compound used therein | UBE INDUSTRIES, LTD. (JP) | 2018-10-09 | — | — | US | disclosed |
| US-20170275311-A1 | NON-AQUEOUS LIQUID ELECTROLYTE, ELECTRICITY STORAGE DEVICE USING SAME, AND PHOSPHORUS COMPOUND USED THEREIN | UBE INDUSTRIES, LTD. (JP) | 2017-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170275311-A1 | NON-AQUEOUS LIQUID ELECTROLYTE, ELECTRICITY STORAGE DEVICE USING SAME, AND PHOSPHORUS COMPOUND USED THEREIN | SCN10A, CACNA2D4, P2RY10 | TSHR 4055/4885LMNA 1341/4885CYP2C19 3584/4885 |
| US-10093688-B2 | Non-aqueous liquid electrolyte, electricity storage device using same, and phosphorus compound used therein | SCN10A, CACNA2D4, P2RY10 | TSHR 3923/4885LMNA 866/4885CYP2C19 3421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.